Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia.
Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia.
复制标题
DOI:
10.1016/j.ijid.2014.09.003
复制
发表时间:
2014-12
期刊:
影响因子:
--
通讯作者:
Albarrak AM
中科院分区:
文献类型:
--
作者:
Saad M;Omrani AS;Baig K;Bahloul A;Elzein F;Matin MA;Selim MA;Al Mutairi M;Al Nakhli D;Al Aidaroos AY;Al Sherbeeni N;Al-Khashan HI;Memish ZA;Albarrak AM
To report the experience with Middle East respiratory syndrome coronavirus (MERS-CoV) infection at a single center in Saudi Arabia. Cases of laboratory-confirmed MERS-CoV occurring from October 1, 2012 to May 31, 2014 were reviewed retrospectively. Information sources included medical files, infection control outbreak investigations, and the preventive medicine database of MERS-CoV-infected patients. Data were collected on clinical and epidemiological aspects and outcomes. Seventy consecutive patients were included. Patients were mostly of older age (median 62 years), male (46, 65.7%), and had healthcare acquisition of infection (39, 55.7%). Fever (43, 61.4%), dyspnea (42, 60%), and cough (38, 54.3%) were the most common symptoms. The majority developed pneumonia (63, 90%) and required intensive care (49, 70%). Infection commonly occurred in clusters. Independent risk factors for severe infection requiring intensive care included concomitant infections (odds ratio (OR) 14.13, 95% confidence interval (CI) 1.58–126.09; p = 0.018) and low albumin (OR 6.31, 95% CI 1.24–31.90; p = 0.026). Mortality was high (42, 60%), and age ≥65 years was associated with increased mortality (OR 4.39, 95% CI 2.13–9.05; p < 0.001). MERS-CoV can cause severe infection requiring intensive care and has a high mortality. Concomitant infections and low albumin were found to be predictors of severe infection, while age ≥65 years was the only predictor of increased mortality.
登录
查看更多内容
影响因子:
56.3
作者:
Cauchemez, Simon;Fraser, Christophe;Van Kerkhove, Maria D.;Donnelly, Christi A.;Riley, Steven;Rambaut, Andrew;Enouf, Vincent;van der Werf, Sylvie;Ferguson, Neil M.
通讯作者:
Ferguson, Neil M.
DOI:
10.1016/s0140-6736(13)60982-4
发表时间:
2013-06-29
期刊:
Lancet (London, England)
影响因子:
--
作者:
Guery B;Poissy J;el Mansouf L;Séjourné C;Ettahar N;Lemaire X;Vuotto F;Goffard A;Behillil S;Enouf V;Caro V;Mailles A;Che D;Manuguerra JC;Mathieu D;Fontanet A;van der Werf S;MERS-CoV study group
通讯作者:
MERS-CoV study group
影响因子:
4.9
作者:
Dyall, Julie;Coleman, Christopher M.;Frieman, Matthew B.
通讯作者:
Frieman, Matthew B.
影响因子:
19
作者:
Puzelli, S.;Azzi, A.;Donatelli, I.
通讯作者:
Donatelli, I.
DOI:
10.1056/nejmoa1306742
发表时间:
2013-08-01
期刊:
The New England journal of medicine
影响因子:
--
作者:
Assiri A;McGeer A;Perl TM;Price CS;Al Rabeeah AA;Cummings DA;Alabdullatif ZN;Assad M;Almulhim A;Makhdoom H;Madani H;Alhakeem R;Al-Tawfiq JA;Cotten M;Watson SJ;Kellam P;Zumla AI;Memish ZA;KSA MERS-CoV Investigation Team
通讯作者:
KSA MERS-CoV Investigation Team